Biochem Soc Trans 44(2):582588 Furman BL (2012) The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent
Multi-dose vials
Overview Since their approval, the labels for anti-obesity GLP-1s (Zepbound, Wegovy, and Saxenda) have included warnings about the potential risk for suicidal ideation and instruct healthcare providers to monitor patients and discontinue use if they experience suicidal thoughts or behaviors
Whether you are considering GLP-1 medications, gastric sleeve surgery, gastric bypass surgery, or another approach, our team can help you determine the most effective path toward achieving your long-term health and weight-loss goals
(Physicians will likely stop prescribing a GLP-1 or dual agonist if you receive a pancreatitis diagnosis.) Your doctor should also reevaluate treatment and dosage if you have any other severe side effects
References Cheema AY, Munir M, Mandala A, Aslam F, Acharya U